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Objectives The purpose of this study was to determine appropriateness of percutaneous coronary intervention (PCI) and
coronary artery bypass graft (CABG) surgery performed in New York for patients without acute coronary syn-
drome (ACS) or previous CABG surgery.
Background The American College of Cardiology Foundation (ACCF) and 6 other societies recently published joint appropri-
ateness criteria for coronary revascularization.
Methods Data from patients who underwent CABG surgery and PCI without acute coronary syndrome or previous CABG
surgery in New York in 2009 and 2010 were used to assess appropriateness and to examine the variation
across hospitals in inappropriateness ratings.
Results Of the 8,168 patients undergoing CABG surgery in New York without ACS/prior CABG who could be rated, 90.0%
were appropriate for revascularization, 1.1% were inappropriate, and 8.6% were uncertain. Of the 33,970 PCI
patients eligible for rating, 28% lacked sufficient information to be rated. Of the patients who could be rated,
36.1% were appropriate, 14.3% were inappropriate, and 49.6% were uncertain. A total of 91% of the patients
undergoing PCI who were classified as inappropriate had 1- or 2-vessel disease without proximal left anterior
descending artery disease and had no or minimal anti-ischemic medical therapy.
Conclusions For patients without ACS/prior CABG, only 1% of patients undergoing CABG surgery who could be rated were
found to be inappropriate for the procedure according to the ACCF appropriateness criteria, but 14% of the PCI
patients who could be rated were found to be inappropriate, and 28% lacked enough noninvasive test informa-
tion to be rated. (J Am Coll Cardiol 2012;59:1870–6) © 2012 by the American College of Cardiology
Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2012.01.050For many years, the American College of Cardiology
(ACC) and the American Heart Association (AHA) have
jointly published and updated guidelines to be considered by
referring physicians when determining what treatments to
recommend. “Indications” have been provided for a variety
of treatments, including percutaneous coronary intervention
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2012, accepted January 12, 2012.(PCI) and coronary artery bypass graft (CABG) surgery
(1,2) for patients with coronary artery disease (CAD).
Recently, the ACC and AHA, in conjunction with the
Society for Cardiovascular Angiography and Interventions
(SCAI), the Society of Thoracic Surgeons (STS), the
American Association for Thoracic Surgery (AATS), and
the American Society of Nuclear Radiology (ASNC), re-
leased appropriate use criteria (AUC) for coronary revascu-
larization to serve as a supplement to the earlier ACC/AHA
See page 1877
guideline documents (3). The process of appropriateness
development, which was described in an earlier publication
(4), derives from methods developed by the RAND Cor-
poration many years ago that are outlined in a more recent
release (5). It consists of identifying clinical scenarios that
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patient. Earlier versions of appropriateness criteria for
CABG surgery and PCI were published and tested many
years ago (6–10).
The new appropriateness criteria use the broad categories
1) acute coronary syndrome (ACS); 2) no ACS/no prior
CABG surgery; and 3) no ACS/prior CABG surgery as the
first means of separating patients into “scenarios” that are
used to identify whether patients are appropriate for revas-
cularization. Within these 3 indications, patients are classi-
fied into scenarios on the basis of number of vessels
diseased/proximal left anterior descending artery (PLAD)
disease, findings on noninvasive testing, amount of anti-
ischemic medical therapy received, and Canadian Cardio-
vascular Society (CCS) angina class. In keeping with the
RAND methodology, patients are rated as appropriate,
uncertain, or inappropriate for revascularization in the first
part of the document, and then selected high-risk patients
who were judged to be appropriate for revascularization are
rated in the same manner with regard to PCI versus CABG
surgery.
A recent publication using data from the National Car-
diovascular Data Registry (NCDR) found that, for non-
acute conditions, 50% of PCI patients were classified as
appropriate, 38% as uncertain, and 12% as inappropriate
(11). The investigators also found substantial variation
across hospitals, with an interquartile range of 6.0% to
16.7%.
The purpose of our study is to use information from New
York State’s CABG surgery and PCI registries to examine
the extent to which actual practice in New York conforms to
the appropriateness recommendations of the ACCF/SCAI/
STS/AATS/AHA/ASNC (henceforth called ACCF crite-
ria) regarding the use of revascularization. Subsequent
analyses examine the same question for each of the specific
scenarios in the ACCF criteria, and examine the variation
across hospitals in the state in conforming to the criteria.
Methods
Data. The databases used in the study were New York
State’s Cardiac Surgery Reporting System and the Percuta-
neous Coronary Interventions Reporting System. These
registries were developed in 1989 and 1991, respectively, for
the purpose of collecting information on all New York
patients undergoing CABG surgery and PCI in nonfederal
hospitals in the state. They contain information on demo-
graphics, comorbidities, left ventricular function, hemody-
namic state, vessels diseased, hospital and operator identi-
fiers, and in-hospital adverse outcomes. As of July 2009,
they also contain information on the extent of anti-ischemic
medical therapy used by patients and noninvasive test
findings, both of which are included in the scenarios used in
the ACCF document. The stress test information includes
standard exercise stress tests, stress echocardiogram, stress
testing with single-photo emission computed tomography, andith cardiac magnetic resonance.
lso, low-, intermediate-, and high-
isk findings are defined and re-
orded. Definitions for these data
lements are identical in the 2 sys-
ems. Data are audited and cross-
hecked against the department’s
cute care hospital discharge data-
ase, the Statewide Planning and
esearch Cooperative System to en-
ure accuracy and completeness.
atients and hospitals. All 40
onfederal hospitals in which
ABG surgery was performed
nd 58 nonfederal hospitals in
ew York in which PCI was
erformed during the study pe-
iod were included in the study.
atients in the study included all
atients who underwent the pro-
edures in these hospitals be-
ween July 1, 2009, and Decem-
er 31, 2010, except patients who
ad ACS and/or had previous
ABG surgery. A total of
0,460 isolated CABG patients
nd 33,970 PCI patients met these criteria. Of these
atients, a rating could not be determined for 2,292 CABG
urgery patients and 9,425 PCI patients, leaving a total of
,168 CABG surgery patients and 24,545 PCI patients for
hom a rating could be determined. Reasons for not being
ble to determine ratings will be discussed in the results
ection.
Each of the numbered indications in Table 2 of the ACCF
document used in the study (indications 12 to 47) is further
classified in the document according to CCS class (asymptom-
atic, class I or II, class III or IV), except indications 18, 19, and
21. Since indication 21 requires fractional flow reserve or
intravascular ultrasonography findings, and the New York
databases do not include intravascular ultrasonography infor-
mation in sufficient detail, it is not included in the study, and
all 3 of its scenarios are missing.
AUC rating assignments. The AUC rating assignments
are determinations of whether each CABG surgery patient
and each PCI patient met the ACCF appropriateness
criteria for revascularization. The recommendations for each
patient were categorized as appropriate, uncertain, or inap-
propriate. Reasons for the inability to determine ratings
were also explored.
Statistical analysis. For each procedure (CABG, PCI), the
number of patients receiving the procedure was summed
across all scenarios and classified according to each of the 3
ratings so that the percentage of patients undergoing each of
the procedures who were appropriate, uncertain, and inap-
propriate could be determined. Ratings were examined for
Abbreviations
and Acronyms
ACC  American College of
Cardiology
ACCF  American College
of Cardiology Foundation
ACS  acute coronary
syndrome(s)
AHA  American Heart
Association
AUC  appropriate use
criteria
CABG  coronary artery
bypass graft
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ascertained.
Other analyses were conducted to determine the range
across hospitals in uncertain and inappropriate ratings for
each procedure after eliminating hospitals with relatively
low volumes. The extent to which variations in rates of
inappropriate (and rates of inappropriate/uncertain, and
inappropriate/uncertain/unrated) PCIs was examined by
using multivariable hierarchical regression with the GLIMMIX
(SAS Institute, Cary, North Carolina) procedure to com-
pute the hospital random effects variation, which was then
used determine the median rate ratio (12). The median rate
ratio is the likelihood of patients with identical clinical char-
acteristics undergoing an inappropriate PCI at 1 randomly
chosen hospital relative to another randomly chosen hospital.
A value of 1 denotes no variation. Also, the relationship
between the inappropriateness rate and hospital volume was
investigated using Spearman’s correlation coefficient.
For patients who could not be rated, reasons were
explored. All tests for statistical significance were 2-sided,
with a p  0.05 significance level, and all statistical analyses
ere performed using SAS version 9.2 (SAS Institute).
esults
here were totals of 10,460 CABG surgery patients and
3,970 PCI patients in the New York registries who met the
efinitions described in the methods (no ACS, no prior
ABG surgery). Of these patients, hospitals had sufficient
nformation to rate 8,168 CABG patients and 24,545 PCI
atients. Of the CABG surgery patients who could be rated,
,372 (90.3%) were appropriate for revascularization ac-
ording to the ACCF criteria, 91 (1.1%) were inappropriate,
nd 705 (8.6%) were uncertain (Table 1). Of the 92 CABG
urgery patients who were inappropriate for revasculariza-
ion, 51 (55.4%) were asymptomatic with 1- or 2-vessel
AD without involvement of PLAD disease, had intermediate-
isk findings on noninvasive testing, and were receiving no
r minimal anti-ischemic medical therapy; and another 20
21.7%) were CCS class I or II with 1- or 2-vessel CAD
ithout PLAD disease, had low-risk findings on noninva-
ive testing, and were receiving no or minimal anti-ischemic
edical therapy. Of the CABG patients rated as uncertain
or revascularization, 113 (16.0%) were CCS class I or II
ith 1- or 2-vessel CAD without PLAD disease with
ntermediate-risk findings on noninvasive testing and re-
eiving no or minimal anti-ischemic medical therapy, 131
18.5%) were CCS class III or IV with 1- or 2-vessel CAD
ithout PLAD disease with intermediate risk findings on
oninvasive testing and receiving no or minimal anti-
schemic medical therapy, and 154 (21.7%) were CCS class
or II with 1- or 2-vessel CAD without PLAD disease and
ad no stress test done, placing them in a scenario that does
ot mention anti-ischemic medical therapy (Table 2).
Of the PCI patients who could be rated, 8,856 (36.1%)ere appropriate, 3,508 (14.3%) were inappropriate, and a2,181 (49.6%) were uncertain (Table 1). A total of 34 of
he 58 hospitals approved to perform PCI in New York
eport data to the NCDR. Patients in these hospitals
omprised 57% of the PCI patients in Table 1, and their
ates of appropriate, uncertain, and inappropriate findings in
ur registry were 36%, 47%, and 17%, respectively, com-
ared with 36%, 53%, and 11% for hospitals not in the
CDR. Why these differences exist is beyond the scope of
his study. It should be noted that 2 differences between our
tudy and the NCDR study with regard to data definitions
nd assignment of patients to acute versus nonacute scenario
roups involved the definition of CCS class (NCDR re-
uests the highest class, and our definition requests the
typical” class) and the definition of acute myocardial
nfarctions, which we defined based on a symptom onset
ime of 24 h and NCDR appears to define on the basis of
days. When we removed the 1,688 myocardial infarction
atients with symptom onset times between 24 h and 7 days
rom the nonacute group that our study was based on, we
btained identical percentages of appropriate, inappropriate,
nd uncertain to the nearest integer.
Of the 3,508 PCI patients who were inappropriate for
evascularization according to the ACCF criteria, 1,583
45.1%) were asymptomatic with 1- or 2-vessel CAD
ithout PLAD disease, had intermediate-risk findings on
oninvasive testing, and were receiving no or minimal
nti-ischemic medical therapy (Table 3). Another 1,203
CI patients (34.3% of all patients inappropriate for PCI
ccording to ACCF criteria) were CCS class I or II with 1-
r 2-vessel CAD without PLAD disease, had low-risk
oninvasive test findings, and were receiving no or minimal
nti-ischemic medical therapy; and another 488 (11.6%)
ere identical to the previous group except that they were
Rating Cases as Appropriatefor Revascularization According toACC/AHA Appropriate Use Criteria Patients*
Table 1
R ting Case as Appropriat
for Revascularization According to




Total cases reported 14,519 81,407
Eligible cases—no ACS, no previous CABG
(% of all cases reported that are eligible)
10,460 (72.04) 33,970 (41.73)
Eligible cases where rating cannot be
determined
2,292 9,425
Cases rated for appropriateness of
revascularization
8,168 24,545







*Patients without prior bypass and without ACS, New York, July 1, 2009, to December 31, 2010.
ACC  American College of Cardiology; ACS  acute coronary syndrome(s); AHA  American
Heart Association; CABG  coronary artery bypass graft surgery; PCI  percutaneous coronary
intervention.symptomatic instead of CCS class I or II. Among the PCI
or desc
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(41.4%) were CCS class I or II with 1- or 2-vessel CAD
without PLAD disease and had no stress test done, placing
them in a scenario with no mention of anti-ischemic
medical therapy in the criteria; and another 3,132 patients
(25.8%) were CCS class I or II with 1- or 2-vessel CAD
without PLAD disease, had intermediate-risk noninvasive
test findings, and were receiving no or minimal anti-
ischemic medical therapy.
For the 46 hospitals with PCI volumes 400, the range
in percent of PCI patients who were inappropriate for
revascularization according to the ACCF criteria was from
1% to 40% (Fig. 1). The median rate ratio was 1.93 (95%
confidence interval: 1.64 to 2.20), indicating that there was
a large variation across hospitals in the chance of patients
with identical clinical characteristics undergoing an inap-
propriate PCI. The value of Spearman’s correlation coeffi-
cient for the relationship between total hospital volume and
hospital inappropriateness rate was very weak (R  0.03).
For CABG surgery, the range of inappropriate cases ac-
cording to ACCF criteria was from 0.0% to 6%.
As indicated in Table 4, of the 9,425 PCI cases for which
a rating could not be determined, 2,834 (30.0%) were in
scenario 18 (1- or 2-vessel disease/no PLAD disease/no
noninvasive testing/asymptomatic), which was not rated by
the ACCF because the writing group considered the like-
lihood of the clinical scenario was so low that rating should
not be performed. These cases would appear to be particu-
Most Common Clinical Scenarios for CABG SurgNo Prior CABG Surgery Classified as InappropriaTable 2 Most Common Clinical Scenari s foNo Prior CABG Surgery Classified a
Rating Anatomy Symptoms
Inappropriate
1-, 2-vessel non-PLAD Asymptomatic
1-, 2-vessel non-PLAD CCS class I–II
Uncertain
1-, 2-vessel non-PLAD CCS class I–II
1-, 2-vessel non-PLAD CCS class III–IV
1-, 2-vessel non-PLAD CCS class I–II
CCS  Canadian Cardiovascular Society; PLAD  proximal left anteri
Most Common Clinical Scenarios for PCI PatienNo Prior CABG Surgery Classified as InappropriaTable 3 Most Common Clinical Scenari s foNo Prior CABG Surgery Classified a
Rating Anatomy Symptoms
Inappropriate
1-, 2-vessel non-PLAD Asymptomatic
1-, 2-vessel non-PLAD CCS class I–II
1-, 2-vessel non-PLAD Asymptomatic
Uncertain
1-, 2-vessel non-PLAD CCS class I–II
1-, 2-vessel non-PLAD CCS class I–II
Appropriate
1-, 2-vessel non-PLAD CCS class I–II
1-, 2-vessel non-PLAD CCS class III–IV
1-, 2-vessel non-PLAD CCS class I–IIAbbreviations as in Tables 1 and 2.larly inappropriate for revascularization because there is no
expectation of survival benefit and no possibility of quality
of life improvement. If these cases were added to the
numerator and denominator in the computation of the
percentage of rated cases that are inappropriate, the per-
centage of inappropriate PCIs would rise from 14.3% to
23.2%. Another 3,171 (33.6%) PCI patients were reported
as having a positive finding on noninvasive testing, but were
classified in a scenario requiring information as to whether
the finding was high risk or not, and were missing such
information. Yet another 3,078 patients (32.7%) were in
scenarios that required noninvasive testing, and the hospital
reported that there was no noninvasive testing done or no
evidence of results in its medical records. We were able to
query the PCI hospitals and confirm that they did not have
information regarding the risk level of positive stress tests
when it was needed for assigning appropriateness. Also, for
cases with stress tests reported as missing when they were
needed for appropriateness ratings, we audited 127 medical
records and found only 8 (6%) had stress test information in
the record.
Of the 2,292 CABG surgery cases for which a rating
could not be determined, 1,619 (70.6%) were also in
scenarios that required noninvasive testing, and the hospital
reported that there was no noninvasive testing done or no
evidence of results in its medical records. Another 571 cases
(24.9%) had a positive stress test result but required an
unavailable risk level to assess appropriateness.
atients With No ACS/ncertain, and AppropriateBG Surgery Patients With No ACS/
ppropriate, Uncertain, and Appropriate
Stress Test Anti-Ischemic Therapy n (%)
termediate risk None/minimal 51 (55.4)
ow risk None/minimal 20 (21.7)
termediate risk None/minimal 113 (16.0)
termediate risk None/minimal 131 (18.5)
ot done No mention 154 (21.7)
ending artery; other abbreviations as in Table 1.
ith No ACS/ncertain, and AppropriateI Patients With No ACS/
ppropriate, Uncertain, and Appropriate
Stress Test Anti-Ischemic Therapy n (%)
ermediate risk None/minimal 1,583 (45.1)
risk None/minimal 1,203 (34.3)
risk None/minimal 488 (11.6)
t done No mention 5,019 (46.3)
ermediate risk None/minimal 3,132 (28.9)
h risk None/minimal 1,248 (14.1)
t done No mention 1,170 (13.2)
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This study assessed the referral patterns for CABG surgery
and PCI in New York State as a function of the scenarios in
the recent appropriateness criteria developed by the ACCF/
SCAI/STS/AATS/AHA/ASNC to assess conformance to
the ACCF criteria. This was done for the portion of the
ACCF appropriateness criteria that related to appropriate-
ness of revascularization relative to medical therapy, not the
appropriateness of PCI versus CABG surgery. The study
was also restricted to the part of the ACCF criteria relating
to patients without ACS or prior CABG surgery because
there is reason to believe that this is the group of patients for
whom practice may be most at odds with the appropriate-
ness criteria (12).
Recent studies have examined guidelines adherence
among patients undergoing PCI (13,14) or CABG surgery
Figure 1 Hospital PCI Inappropriateness Percentages
Shown is the number of hospitals in different ranges of percutaneous coronary int
Note that the overall inappropriate percentage is 14.3%.





Eligible cases where rating cannot be determined 2,292 9,425
Scenario 18: 1- or 2-vessel disease, no PLAD, no
noninvasive testing. Asymptomatic; AUC gives no rating
64 2,834
Scenario 19: 1- or 2-vessel disease, no PLAD, no IVUS/FFR;
no noninvasive testing. Asymptomatic; AUC gives no rating
2 12
No vessels diseased (stenosis 50% for LM,
70% all others)
36 330
Stress test result  positive, risk unavailable 571 3,171
Noninvasive testing not done or results unknown
(no high/moderate risk)
1,619 3,078AUC  appropriate use criteria; FFR  fractional flow reserve; IVUS  intravascular ultrasonogra-
hy; LM  left main disease; other abbreviations as in Tables 1 and 2.(15), or both PCI and CABG surgery (16), and 2 of them
have also demonstrated a direct relationship between guide-
lines adherence and better outcomes (13,14).
One of these studies was an earlier study in New York
that used ACC/AHA guidelines that preceded their appro-
priateness criteria (1,2) to show that among patients who
were indicated for CABG surgery and not PCI, a total of
50% were recommended for CABG surgery and 34% were
recommended for PCI, whereas among patients indicated
for PCI and not CABG surgery, 93% were recommended
for PCI, and only 5% were recommended for CABG
surgery (16).
A recent study similar to ours examined the appropriateness
of PCI (not guidelines adherence) using the same ACCF
appropriateness criteria used in our study, and found that only
50% of the PCIs for nonacute conditions in the NCDR were
appropriate (12). Our study found that of the New York
patients undergoing PCI without ACS or prior CABG sur-
gery for whom a rating could be determined, 8,856 (36.1%)
were appropriate, 3,508 (14.3%) were inappropriate, and
12,181 (49.6%) were uncertain. These results are similar to, but
somewhat more discordant with, the ACCF criteria than the
other recent findings, which were that for patients who
underwent PCI for nonacute conditions, 50.4% were appro-
priate, 11.6% were inappropriate, and 38.0% were uncertain.
The overall findings of high use of PCI are consistent
with the earlier study in New York described, which found
that many patients indicated only for CABG surgery had
received a recommendation for PCI (16). It is also consis-
tent with the findings of another study, which compared
utilization of CABG surgery and PCI in New York and
Ontario. In that study, Ko et al. (17) found that among
ion (PCI) inappropriateness (for hospitals with volumes 400).erventnon–acute myocardial infarction patients in 2004 through
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PCIs was 2.5 times higher (95% confidence interval: 2.2 to
2.5) in New York, whereas there was no significant differ-
ence in the age- and sex-adjusted population-based rates of
CABG surgery. Caveats of this study are that the number of
patients in each region with CAD, and patient preferences,
are unknown.
As noted earlier, one respect in which this study differs
from the study by Chan et al. (11) is that our study also
includes an assessment of the appropriateness of revascular-
ization for CABG surgery patients. Findings were that 90%
of all patients undergoing CABG surgery were judged to be
appropriate for revascularization, only 1% were inappropri-
ate, and 9% were uncertain. Thus, there was a very high
correspondence between choice of CABG surgery and the
ACCF criteria for revascularization. We hypothesize that a
reason why CABG surgery patients were found to be rarely
inappropriate in comparison with PCI is that a relatively
large percentage of CABG surgery was performed on
patients with severe CAD (3-vessel disease and left main
disease). Also, CABG utilization may be curtailed as a result
of the greater invasiveness and perceived (whether correct or
not) risks of CABG.
Thus, in concert, these 3 studies consistently suggest an
overuse of PCI, with seemingly no significant overuse of
CABG surgery. The practice pattern variation was quite
large, and the treatment recommended to patients without
ACS was very much dependent on the hospital in which
they were treated. This is very important because it means
that even if interventional cardiologists disagree in general
with the ACCF ratings, as a group they do not seem to have
consistency with regard to how they choose patients for
PCI.
A major difference between the ACCF criteria and actual
practice appears to be the importance of patients with 1- or
2-vessel disease without PLAD disease being on maximal
anti-ischemic medical therapy, having high-risk findings on
noninvasive stress testing, and/or having CCS class II or IV
(without unstable angina). The only scenarios deemed
appropriate for revascularization by the ACCF had at least
1 of these 3 criteria for patients with 1- or 2-vessel disease
without PLAD disease. In practice, many patients without
any of these criteria underwent PCI.
Another important finding of our study is that of the
33,970 PCI patients without ACS or prior CABG surgery,
an appropriateness rating could not be determined for 9,425
(27.7%) of the patients. The primary reasons for this were
that either there was no medical record documentation
when needed regarding noninvasive test results, or the
documented results of the noninvasive tests were not spe-
cific enough to determine whether the results were highly
positive.
A caveat of the study is that we were unable to assess the
degree of underuse of CABG surgery and PCI according to
the ACCF criteria because the New York registries only
contain data for patients who underwent those procedures.Also, it is important to note that the appropriateness criteria
that were examined in this study were published in February
2009, and the study was based on data from July 2009
through 2010. It is possible that some clinicians were not
aware of the criteria during part or all of the study period.
Furthermore, as pointed out in the document presenting the
ACCF appropriateness criteria, some PCIs classified as
inappropriate may have been performed on patients with
conditions not covered by the criteria who were best served
by PCI (3). It is expected that these would be rare
circumstances that would not account for the substantial
interhospital variations in inappropriateness found in our
study.
Conclusions
Our study: 1) reinforces earlier findings regarding the
relatively low percentage of patients undergoing PCI for
reasons deemed appropriate by the ACCF; 2) provides new
evidence that the ACCF criteria indicate very high levels of
appropriateness for CABG surgery; and 3) demonstrates
that in addition to the many PCI patients deemed inappro-
priate or uncertain for the procedure, there are many more
for whom proper judgment of appropriateness cannot be
made for lack of supporting information. Our intent is to
share these findings with clinicians and to work collabora-
tively to reduce inappropriate clinical decisions and varia-
tions in hospital and cardiologist practice patterns.
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